uniQure NV Hits Day High with 78.44% Surge Amid Market Decline

uniQure NV, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, achieving an impressive intraday high of USD 49.70. The stock surged by 78.44% on June 17, 2026, showcasing a remarkable performance compared to the S&P 500, which declined by 1.21% on the same day. Over the past week, uniQure NV has demonstrated a robust gain of 79.57%, while its one-month performance stands at 78.04%. The stock's year-to-date performance is notable as well, with a return of 101.25%, significantly outpacing the S&P 500's 8.39%. In the last year, uniQure NV has delivered a staggering 225.63% return, far exceeding the S&P 500's 24.03%. The company reported net sales of USD 3.56 million for the quarter, reflecting a growth of 127.31%. However, it is important to note that the stock is trading at a higher risk compared to its historical valuations. With institutional holdings at 100%, uniQure NV continues to attract attention in the market, underscoring its strong position within the industry.